Altimmune
Bo Li has a strong background in drug product development and delivery technologies. Currently, they are working as a Senior Director at Altimmune, Inc., where they formulate drug product development strategies and explores novel delivery technologies. Prior to this, they worked at Emergent BioSolutions as a Director, overseeing the development and manufacturing of therapeutic agents for emergency treatments. Bo also led combination product development for emergency delivery solutions. Before that, Bo Li was a Senior Scientist at MedImmune, leading a team focused on developing novel delivery technologies for drug delivery. Bo has also held positions at Bristol-Myers Squibb and Medarex.
Bo Li completed their Bachelor's degree in Chemical Engineering from Zhejiang University from 1989 to 1993. They then went on to earn a Doctor of Philosophy (Ph.D.) in Chemical Engineering from the University of Cincinnati from 1997 to 2003.
Altimmune
Altimmune is a clinical stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. We strategically employ our two distinct and complementary immune platform technologies to create innovative candidates for important diseases.